The blockbuster ISCHEMIA trial is headlining the American Heart Association (AHA) 2019 Scientific Sessions, but it is by no means the only trial with the potential to impact patient care. AHA program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results